Ever since the evolution of the HIV/AIDS pandemic, researchers have long sought effective strategies to prevent HIV infection or help the body keep the virus in check after infection has occurred. In addition to a decades-long effort to develop an effective vaccine and continuing research to find less toxic drugs, some researchers are focusing on another strategy—modifying the genes of host cells to make them resistant to infection.
“To date, vaccines and current drug therapies have shown a limited ability to achieve functional control of HIV infection, as defined by a state where patients no longer are required to take medication on a daily basis,” said Carl June, MD, a professor of immunology at the University of Pennsylvania’s Perelman School of Medicine.
Hampton T. Gene Researchers Work to Engineer HIV-Resistant Cells. JAMA. 2014;312(4):323–325. doi:10.1001/jama.2014.8659
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: